ROL vs TRVI · P/E 41, rev $1.99B vs $2.32B cap
Rollins Inc (ROL) versus Trevi Therapeutics Inc (TRVI) — a side-by-side from cached financials, not a winner call.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Trevi Therapeutics Inc (TRVI) is a biotechnology company listed on NASDAQ.
Latest reported ROL revenue for 2026-06-30 was $1.99B. Net income was $251.7M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
TRVI does not have a complete income-statement cache yet.
ROL currently screens at market cap $21.73B and trailing P/E 41.4. TRVI currently screens at market cap $2.32B.
Not investment advice. Open the ROL and TRVI stock pages for the full models.
Not investment advice.